SLU-PP-332 500mcg x 60 Capsules

Description

DESCRIPTION

SLU-PP-332 500mcg capsules deliver a synthetic small-molecule ERRα/β/γ pan-agonist studied in research models for activity at estrogen-related receptor signaling pathways, mitochondrial biogenesis, and oxidative metabolism in cell culture and preclinical models.

RESEARCH AREAS

• ERR receptor agonism — studied in cell culture for pan-agonist activity at ERRα, ERRβ, and ERRγ.
• Mitochondrial biogenesis research — investigated in preclinical models for PGC-1α pathway signaling.
• Oxidative metabolism — characterized in cell models for fatty acid oxidation pathway activity.
• Comparative small-molecule research — studied alongside other ERR modulator compounds in published literature.

WHAT RESEARCHERS LOOK AT

• Mechanism: pan-agonist activity at estrogen-related receptors in research models.
• PGC-1α coactivation and downstream mitochondrial signaling in cell culture.
• Fatty acid oxidation pathway activity in preclinical metabolic models.
• Comparative profiling alongside other mitochondrial pathway modulators.

QUICK SPECS

• • Form: Capsules
  • Amount per capsule: 500 mcg
  • Count: 60 capsules

• Purity: ≥99% (HPLC)
• Storage: Cool, dry place, protect from light

IDENTITY BASICS

• Type: Synthetic small molecule (non-peptide), ERR pan-agonist
• Formula / M.W.: Not publicly disclosed in full literature
• CAS: Not publicly assigned

SELECTED RESEARCH

• ERRα/γ agonist characterization:
  https://pubmed.ncbi.nlm.nih.gov/37080197/
• Mitochondrial biogenesis and ERR signaling:
  https://pubmed.ncbi.nlm.nih.gov/36681080/
• ERR receptor biology review:
  https://pubmed.ncbi.nlm.nih.gov/26160145/

⚠️ DISCLAIMER

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.